Search clinical trials for: H1N1 2009

Total 4146 results

PHAC/CIHR Influenza Research Network
University of Manitoba; University of British Columbia; CHU de Quebec-Universite... and other collaborators

Unknown

Clinical Investigation on Allergic-like Reactions and Oculo-respiratory Syndrome After the H1N1 Pandemic Vaccine

Allergy | Anaphylaxis | Oculorespiratory Syndrome | Allergic-like Reactions

Canada
Adimmune Corporation

Completed

A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant Women

Adverse Drug Reactions
Julie Dawson

Active, not recruiting

Outcomes of Drug Coated Balloon Angioplasty, A UK Real Life Experience From 2009 to 2015 (DCBNORWICH)

Ischaemic Heart Disease

United Kingdom
NPO Petrovax

Completed

A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus

Vaccine Reaction | Influenza | Influenza, Human | Influenza A | Acute Respiratory Infection | Influenza Type B | Flu | Influenza A H3N2 | Influenza A H1N1 | Flu, Human | Influenza Epidemic

Russian Federation
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults

Influenza

Belgium
Hospital Clinica Nova

Terminated

Vitamine D3 Supplementation in Patients With Serum Values +/- 20ng/ml

Covid19 | Influenza A | H1N1 Influenza | Influenza B

Mexico
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children

Influenza

Germany
GlaxoSmithKline

Completed

Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older

Influenza

United States, Canada
Betta Pharmaceuticals Co., Ltd.

Unknown

Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients

Non-small-cell Lung Cancer

China
Cadila Pharnmaceuticals
New Millennium Indian Technology Leadership Initiative (NMITLI) program of...

Completed

Effect of CPL-2009-0031 in the Treatment of Patients With Uncontrolled Type 2 Diabetes Mellitus

Uncontrolled Type 2 Diabetes Mellitus

India
Novartis Vaccines

Completed

Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009

Interpandemic Influenza

Italy
Betta Pharmaceuticals Co., Ltd.

Unknown

Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma

Adenocarcinoma | EGFR Positive Non-small Cell Lung Cancer

China
Rabin Medical Center

Unknown

Prevention of Capecitabine Induced Hand and Foot Syndrome

Cancer

Israel
Universidad de Guanajuato
University Medical Center Groningen; Hospital General Regional de León

Unknown

Tomographic Findings in COVID-19 and Influenza (TOMOCOVIDMX)

Covid19 | SARS-CoV-2 | Computed Tomography | H1N1 Influenza

Mexico
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults

Influenza

Belgium
GlaxoSmithKline

Completed

Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults

Influenza

United States, Canada
University of Versailles
Assistance Publique - Hôpitaux de Paris

Terminated

Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu (CORTIFLU)

Pneumonia, Viral | Influenza in Humans

France
National Cancer Institute, Naples

Completed

Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer (TIR-2009-01)

Thyroid Cancer

Italy
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years

Influenza Vaccines

Canada
GlaxoSmithKline

Completed

A Study for Evaluation of Immunogenicity and Reactogenicity of FluarixTM / Influsplit SSW® 2009/2010 in Adults

Influenza

Germany
Masonic Cancer Center, University of Minnesota

Terminated

Influenza Vaccine Post Allogeneic Transplant

Hematologic Malignancy | Hematopoietic Stem Cell Transplant

United States
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010

Seasonal Influenza

Italy
Carmel Medical Center

Withdrawn

Correlation Between IgE Parameters and the Response to Omalizumab in Subjects With Severe Asthma (OM-2009-XO)

Severe Allergic Asthma

Israel
Public Health England
Institute of Child Health

Completed

A Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™). (LAIV Immuno)

Live Attenuated Influenza Vaccine

United Kingdom
GlaxoSmithKline

Completed

Immunogenicity and Safety of Vaccine GSK2340272A (H1N1) and GSK Biologicals Fluarix™ Vaccine When Co-administered in Elderly

Influenza

Sweden
QIAGEN Gaithersburg, Inc

Completed

Collection and Extraction of Respiratory Specimens

Influenza

United States
GlaxoSmithKline

Completed

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection

Influenza, Human

Japan
GlaxoSmithKline

Completed

Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

Influenza

Germany
GlaxoSmithKline

Completed

Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)

Influenza

Germany
GlaxoSmithKline

Completed

A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza (ZORO)

Influenza, Human

Australia, Taiwan, Korea, Republic of, United States, Belgium, Canada, Germany, South Africa, Spain, United Kingdom, New Zealand, Thailand, India, China, Brazil, Hong Kong, Slovakia, Russian Federation, Denmark, Mexico, Czechia, H... and more
JSehouli

Completed

Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer (TRIAS 2009)

Ovarian Cancer

Germany
GlaxoSmithKline

Completed

A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ / Influsplit SSW® 2008/2009 in Adults

Influenza

Germany
Symetis SA

Completed

Feasibility Trial on ACURATE™ Transapical Implantation in Patients With Severe Symptomatic Aortic Stenosis (2009-01) (TA-FIM)

Aortic Stenosis Symptomatic

Germany
PETHEMA Foundation

Terminated

PROCEDYTE: Depocyte® Administration (Liposomal Cytarabine) as Prophylaxis of Neuromeningeal Infiltration in Acute Lymphoblastic Leukemia (2009-009422-92)

Acute Lymphoblastic Leukemia

Spain
arpa pungrasamee

Completed

Detection of Minimal Change Esophagitis by I-scan

Non-erosive Reflux Disease | Gastro-esophageal Reflux Disease

Thailand
Kaohsiung Medical University Chung-Ho Memorial...

Recruiting

Naldebain and Video-assisted Thoracoscopic Surgery

Analgesia | Satisfaction, Patient | Itching | Injection Site Reaction | Nausea and Vomiting, Postoperative

Taiwan
University of Cologne

Completed

Effect of Red Wine, White Wine and Beer on Contrast-Medium Induced Acute Kidney Injury (RenPro-II-WINE)

Chronic Renal Failure/ Kidney Disease | Contrast-medium Induced Acute Kidney Injury

Germany
GlaxoSmithKline

Terminated

Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children

Influenza

Czechia
Novartis Pharmaceuticals
Genentech, Inc.

Completed

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Persistent Allergic Asthma

China
National Taiwan University Hospital

Unknown

Follow-up of Immunogenicity of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Healthy Volunteers After 6 Months

Influenza
The University of Hong Kong

Completed

Direct and Indirect Benefits of Influenza Vaccination in Schools and Households

Acute Respiratory Infection | Influenza-like Illness | Influenza Virus Infection

Hong Kong
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Effect of MK-8669 (Ridaforolimus) on QTc Interval in Participants With Advanced Cancer (MK-8669-037)

Metastatic or Locally Advanced Cancer
Bayer

Completed

Occurrence and Trend of Pregnancies Growing Outside the Womb (Ectopic Pregnancy) 2009-2018. A Study on a Defined Group of Persons

Pregnancy, Ectopic

United States
University of Sao Paulo General Hospital

Completed

Evaluation of Influenza A/H3N2 Vaccine in Patients With Rheumatologic Diseases

Sjogren's Syndrome | Systemic Lupus

Brazil
GlaxoSmithKline

Completed

Immunogenicity & Safety Study of Fluviral® (2009 - 2010 Season) in Adults Aged 18 to 60 Years and Over 60 Years

Influenza, Human

Canada
GlaxoSmithKline

Completed

Safety and Immunogenicity of H1N1 Vaccines in Children Aged 6 Months to Less Than 9 Years of Age

Influenza

Canada, United States
VaxInnate Corporation

Completed

Comparative Safety and Immunogenicity of VAX128A, VAC128B and VAX128C Novel H1N1 Influenza Vaccine in Healthy Adults (VAX128-01)

Influenza

United States
Johns Hopkins University
Children's Hospital Colorado; US Department of Veterans Affairs; Centers for... and other collaborators

Completed

The Respiratory Protection Effectiveness Clinical Trial (ResPECT)

Paramyxoviridae Infections | Influenza | Coronavirus | Respiratory Syncytial Viruses | Rhinovirus

United States
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)

Lymphoma | Multiple Myeloma | Tumors
Merck Sharp & Dohme LLC
Ariad Pharmaceuticals

Completed

Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED)

Cancer

3

Subscribe